A client with myasthenia gravis receives a new prescription for pyridostigmine. Which information should the nurse obtain to prior to administering the medication?

A. Trouble sleeping: Sleep disturbances are not a major concern before administering pyridostigmine. Although insomnia can occur with many medications, it is not directly impacted by pyridostigmine, nor does it influence the decision to give the drug safely. B. Recent oral intake: Pyridostigmine should be given on a consistent schedule relative to meals to optimize absorption and minimize gastrointestinal side effects. Additionally, coordinating dosing with food can help maximize muscle strength for chewing and swallowing, critical concerns in myasthenia gravis. C. Unexplained weight loss: While significant weight loss could suggest disease progression or nutritional problems, it is not immediately relevant to the safe administration of pyridostigmine. Monitoring weight is important long-term but does not alter short-term dosing considerations. D. Difficulty with urination: Pyridostigmine can affect smooth muscle function, including the bladder, but urinary issues are not the primary focus prior to administration. Ensuring safe medication absorption and effectiveness related to food intake is more critical immediately before dosing.